Unnamed: 0,title,date,stock,sentiment
1012958.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,PKI,positive
1012959.0,Stocks That Hit 52-Week Highs On Friday,2020-06-05 10:30:00-04:00,PKI,neutral
1012960.0,Stocks That Hit 52-Week Highs On Wednesday,2020-06-03 10:45:00-04:00,PKI,neutral
1012961.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,PKI,neutral
1012962.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses.,2020-05-26 11:58:00-04:00,PKI,positive
1012963.0,'PerkinElmer Receives AOAC INTERNATIONAL First Action Official Methods of Analysis (OMA) Status for Solus One Salmonella Assay' -Financial Post,2020-05-11 09:11:00-04:00,PKI,neutral
1012964.0,"UBS Maintains Neutral on PerkinElmer, Raises Price Target to $96",2020-05-07 12:19:00-04:00,PKI,neutral
1012965.0,"CFRA Maintains Hold on PerkinElmer, Lowers Price Target of $94",2020-05-06 12:17:00-04:00,PKI,negative
1012966.0,"Baird Maintains Outperform on PerkinElmer, Raises Price Target of $99",2020-05-06 12:01:00-04:00,PKI,neutral
1012967.0,"JP Morgan Maintains Neutral on PerkinElmer, Raises Price Target to $85",2020-05-06 10:23:00-04:00,PKI,positive
1012968.0,PerkinElmer shares are trading higher after the company reported better-than-expected Q1 EPS results.,2020-05-06 09:43:00-04:00,PKI,positive
1012969.0,Perkin Elmer Sees Q2 Adj. EPS At Least $0.65,2020-05-05 16:44:00-04:00,PKI,neutral
1012970.0,PerkinElmer Withdraws FY20 Guidance,2020-05-05 16:43:00-04:00,PKI,neutral
1012971.0,"PerkinElmer Q1 Adj. EPS $0.670 Beats $0.550 Estimate, Sales $652.400M Miss $652.710M Estimate",2020-05-05 16:43:00-04:00,PKI,negative
1012972.0,PerkinElmer Reports FDA Emergency Use Authorization For Serological Test To Identify Coronavirus Antibodies,2020-05-05 09:23:00-04:00,PKI,negative
1012973.0,"UBS Maintains Neutral on PerkinElmer, Lowers Price Target to $95",2020-04-28 11:41:00-04:00,PKI,negative
1012974.0,"Citigroup Maintains Neutral on PerkinElmer, Raises Price Target to $85",2020-04-20 13:33:00-04:00,PKI,neutral
1012975.0,"Stifel Maintains Buy on PerkinElmer, Lowers Price Target to $80",2020-04-02 11:31:00-04:00,PKI,negative
1012976.0,"Wells Fargo Maintains Equal-Weight on PerkinElmer, Lowers Price Target to $80",2020-03-30 12:32:00-04:00,PKI,positive
1012977.0,Parkland Fuel to Reduce 2020 Capex by $275M to $300M,2020-03-30 07:24:00-04:00,PKI,neutral
1012978.0,"Barclays Maintains Equal-Weight on PerkinElmer, Lowers Price Target to $94",2020-03-26 11:02:00-04:00,PKI,negative
1012979.0,"The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down",2020-03-25 07:29:00-04:00,PKI,neutral
1012980.0,"A Peek Into The Markets: US Stock Futures Surge After Senate, White House Strike Deal On Coronavirus Stimulus Package",2020-03-25 06:11:00-04:00,PKI,negative
1012981.0,"7 Stocks To Watch For March 25, 2020",2020-03-25 05:12:00-04:00,PKI,neutral
1012982.0,PerkinElmer Reports FDA Provided Emergency Use Authorization For Co.'s Coronavirus RT-PCR Test,2020-03-24 17:25:00-04:00,PKI,negative
1012983.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,PKI,negative
1012984.0,"Citigroup Maintains Neutral on PerkinElmer, Lowers Price Target to $70",2020-03-20 09:34:00-04:00,PKI,negative
1012985.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,PKI,negative
1012986.0,"Perkinelmer Says Expects Q1 2020 Revenue and EPS, Both on a GAAP and Non-GAAP Basis, to Be Below Company's Previously Communicated Guidance",2020-03-09 06:09:00-04:00,PKI,neutral
1012987.0,PerkinElmer shares are trading lower after the company issued Q1 and FY20 EPS guidance below analyst estimates.,2020-01-28 11:06:00-05:00,PKI,neutral
1012988.0,"UBS Maintains Neutral on PerkinElmer, Raises Price Target to $100",2020-01-28 11:06:00-05:00,PKI,neutral
1012989.0,"PerkinElmer Sees Q1 Adj. EPS $0.70 vs $0.84 Est., Sales $700M vs $699.93M Est.; Sees FY20 Adj. EPS $4.50-$4.60 vs $4.63 Est., Sales $3.05B-$3.09B vs $3.08B Est.",2020-01-27 16:18:00-05:00,PKI,neutral
1012990.0,"PerkinElmer Q4 Adj. EPS $1.35 Beats $1.33 Estimate, Sales $805.5M Beat $800.98M Estimate",2020-01-27 16:17:00-05:00,PKI,neutral
1012991.0,"Earnings Scheduled For January 27, 2020",2020-01-27 04:12:00-05:00,PKI,neutral
1012992.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,PKI,positive
1012993.0,"Citigroup Initiates Coverage On PerkinElmer with Neutral Rating, Announces $100 Price Target",2020-01-07 07:02:00-05:00,PKI,neutral
1012994.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,PKI,positive
1012995.0,"Evercore ISI Group Upgrades PerkinElmer to Outperform, Raises Price Target to $114",2020-01-02 06:53:00-05:00,PKI,neutral
1012996.0,PerkinElmer Press Release Confirms First FDA-Approved Assay Kit To Screen For DMD In Newborns,2019-12-13 09:20:00-05:00,PKI,neutral
1012997.0,UPDATE: 'FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy' -FDA News Website,2019-12-12 11:54:00-05:00,PKI,neutral
1012998.0,PerkinElmer Shares Spike To Session High On Volume Amid Report FDA Has Authorized First Test To Aid In Newborn Screening For DMD,2019-12-12 11:53:00-05:00,PKI,positive
1012999.0,"Benzinga's Top Upgrades, Downgrades For November 15, 2019",2019-11-15 09:59:00-05:00,PKI,positive
1013000.0,"Stifel Nicolaus Initiates Coverage On PerkinElmer with Buy Rating, Announces $102 Price Target",2019-11-15 06:47:00-05:00,PKI,neutral
1013001.0,"Piper Jaffray Downgrades PerkinElmer to Neutral, Lowers Price Target to $89",2019-10-31 06:46:00-04:00,PKI,negative
1013002.0,PerkinElmer Sees FY19 Adj. EPS $4.07 vs $4.04 Estimate,2019-10-30 16:22:00-04:00,PKI,neutral
1013003.0,"PerkinElmer Q3 Adj. EPS $1.06 Beats $1.01 Estimate, Sales $706.923M Miss $715.89M Estimate",2019-10-30 16:21:00-04:00,PKI,negative
1013004.0,PerkinElmer Reports Its Genomics Unit Will Begin Processing Samples With Vanadis Non-Invasive Prenatal Testing System,2019-10-29 08:46:00-04:00,PKI,neutral
1013005.0,"UBS Maintains Neutral on PerkinElmer, Lowers Price Target to $92",2019-10-18 08:09:00-04:00,PKI,negative
1013006.0,PerkinElmer Press Release Highlights Launch Of PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit As Alternative To IVF Embryo Biopsies,2019-10-14 10:00:00-04:00,PKI,neutral
1013007.0,"Benzinga's Top Upgrades, Downgrades For September 26, 2019",2019-09-26 09:40:00-04:00,PKI,positive
1013008.0,Bank of America Upgrades PerkinElmer to Buy,2019-09-26 06:40:00-04:00,PKI,neutral
1013009.0,"Shares of diagnostics and research companies are trading higher in sympathy with Syneos Health, which reported strong Q2 results and raised FY19 guidance.",2019-08-06 13:54:00-04:00,PKI,positive
1013010.0,80 Biggest Movers From Yesterday,2019-07-31 05:28:00-04:00,PKI,neutral
1013011.0,58 Stocks Moving In Tuesday's Mid-Day Session,2019-07-30 12:39:00-04:00,PKI,neutral
1013012.0,Perkin Elmer shares are trading lower after the company reported worse-than-expected Q2 sales results.,2019-07-30 11:44:00-04:00,PKI,neutral
1013013.0,"UBS Maintains Neutral on PerkinElmer, Raises Price Target to $101",2019-07-30 09:46:00-04:00,PKI,neutral
1013014.0,42 Stocks Moving In Tuesday's Pre-Market Session,2019-07-30 08:14:00-04:00,PKI,neutral
1013015.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,PKI,neutral
1013016.0,Perkin Elmer shares are trading lower after the company reported worse-than-expected Q2 sales results.,2019-07-29 16:32:00-04:00,PKI,neutral
1013017.0,PerkinElmer FY19 Adj. EPS $4.02-$4.07 vs $3.82 Estimate,2019-07-29 16:29:00-04:00,PKI,neutral
1013018.0,"PerkinElmer Q2 EPS $1, Inline, Sales $722.517M Miss $729.81M Estimate",2019-07-29 16:29:00-04:00,PKI,negative
1013019.0,Raymond James Initiates Coverage On Parkland Fuel with Outperform Rating,2019-07-10 08:54:00-04:00,PKI,neutral
1013020.0,PerkinElmer Raises FY19 EPS $4.02-$4.07 vs $4.03 Estimate,2019-04-25 17:46:00-04:00,PKI,neutral
1013021.0,"PerkinElmer Q1 Adj. EPS $0.69 Beats $0.66 Estimate, Sales $648.737M Beat $644.87M Estimate",2019-04-25 17:46:00-04:00,PKI,neutral
1013022.0,30 Stocks Moving In Monday's Pre-Market Session,2019-04-22 08:16:00-04:00,PKI,neutral
1013023.0,"UPDATE: Goldman Upgrades PerkinElmer, Adds To Conviction Buy List As Firm Sees '2019 as a continuation of the growth acceleration seen in 2018 with overly conservative guidance, with consensus estimates largely mirroring management expectations'",2019-04-09 09:51:00-04:00,PKI,positive
1013024.0,PerkinElmer shares are trading higher after Goldman Sachs upgraded the company's stock from Neutral to Buy and added it to the Conviction Buy list.,2019-04-09 09:36:00-04:00,PKI,positive
1013025.0,"Benzinga's Top Upgrades, Downgrades For April 9, 2019",2019-04-09 09:16:00-04:00,PKI,positive
1013026.0,"Goldman Sachs Upgrades PerkinElmer to Buy, Adds To Conviction Buy List",2019-04-09 06:21:00-04:00,PKI,neutral
1013027.0,"PerkinElmer Q4 EPS $1.18 Beats $1.16 Estimate, Sales $756.3M Beat $746.61M Estimate",2019-01-31 16:46:00-05:00,PKI,neutral
1013028.0,"Earnings Scheduled For January 31, 2019",2019-01-31 04:01:00-05:00,PKI,neutral
1013029.0,PerkinElmer Earlier Announced Achim von Leoprechting Has Been Promoted To CEO,2019-01-15 08:29:00-05:00,PKI,positive
1013030.0,"Needham Initiates Coverage On PerkinElmer with Hold Rating, Announces $79 Price Target",2019-01-03 08:26:00-05:00,PKI,neutral
1013031.0,Janney Capital Downgrades PerkinElmer to Neutral,2018-11-02 08:26:00-04:00,PKI,neutral
1013032.0,Akoya Biosciences Acquires Phenoptics Portfolio from PerkinElmer; Financial Terms Not Disclosed,2018-11-01 04:51:00-04:00,PKI,neutral
1013033.0,PerkinElmer shares are down 8.0% after the company missed Q3 earnings estimates and cut FY18 guidance.,2018-10-31 17:46:00-04:00,PKI,negative
1013034.0,PerkinElmer Cuts FY18 Adj. EPS Guidance From $3.65 To $3.60 vs $3.66 Estimate,2018-10-31 16:42:00-04:00,PKI,negative
1013035.0,"PerkinElmer, Inc. Q3 EPS $0.90 Misses $0.92 Estimate, Sales $674.313M Miss $676.43M Estimate",2018-10-31 16:42:00-04:00,PKI,negative
1013036.0,"Stocks Trading Ex Dividend For Thurs., Oct. 18, 2018",2018-10-18 06:53:00-04:00,PKI,neutral
1013037.0,"Stocks That Will Be Trading Ex Dividend Thurs., Oct. 18, 2018",2018-10-17 10:21:00-04:00,PKI,neutral
1013038.0,"Morgan Stanley Maintains Overweight on PerkinElmer, Raises Price Target to $100",2018-10-10 07:52:00-04:00,PKI,negative
1013039.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,PKI,neutral
1013040.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,PKI,neutral
1013041.0,"Stocks That Made New 52-Week Highs So Far Today Include: Becton Dickinson, PerkinElmer, TJX Companies, Medtronic, Danaher, Mastercard, Visa, Illumina, Motorola Solutions, Salesforce, Ross Stores, Edward Lifesciences, and Boston Scientific",2018-09-26 12:58:00-04:00,PKI,positive
1013042.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,PKI,neutral
1013043.0,"Stocks That Made New 52-Week Highs So Far Today Include: Mosaic, Cooper Companies, Pfizer, Gartner, Yum Brands, Danaher, Anthem, Nike, Cisco, Honeywell, Advance Auto Parts, and Clorox",2018-09-21 12:55:00-04:00,PKI,neutral
1013044.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,PKI,neutral
1013045.0,"Stocks That Made New 52-Week Highs So Far Today Include: NiSource, Pfizer, United Continental, UDR, Kellogg, Arthur J. Gallagher, PerkinElmer, Paypal, Thermo Fisher, Honeywell, Visa, American Express, Nike, Intuit, Boston Scientific, Microsoft, and AMD",2018-09-13 11:43:00-04:00,PKI,positive
1013046.0,"Stocks That Made New 52-Week Highs Yesterday, September 6th",2018-09-07 16:47:00-04:00,PKI,neutral
1013047.0,"Stocks Which Set New 52-Week High Yesterday, September 5th",2018-09-06 08:48:00-04:00,PKI,neutral
1013048.0,"Benzinga's Top Upgrades, Downgrades For September 5, 2018",2018-09-05 09:10:00-04:00,PKI,positive
1013049.0,"Barclays Upgrades PerkinElmer to Equal-Weight, Raises Price Target to $90",2018-09-05 06:13:00-04:00,PKI,neutral
1013050.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,PKI,neutral
1013051.0,"Stocks That Made New 52-Week Highs Today Include: FLIR Systems, Textron, Darden Restaurants, United Continental, Intuitive Surgical, TJX, NetApp, Illumina, First Energy, NVIDIA, Microsoft, Visa, and Paypal",2018-08-30 15:08:00-04:00,PKI,positive
1013052.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,PKI,neutral
1013053.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,PKI,neutral
1013054.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,PKI,neutral
1013055.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,PKI,neutral
1013056.0,"Stocks That Made New 52 Week Highs So Far Today Include: PerkinElmer, Eli Lilly, Zoetis, Apple, Simon Property Group, Global Payments, and Church & Dwight",2018-08-02 11:09:00-04:00,PKI,neutral
1013057.0,PerkinElmer Raises FY18 Adj. EPS Outlook From $3.60 to $3.65 vs $3.61 Est.,2018-08-01 16:26:00-04:00,PKI,neutral
1013058.0,PerkinElmer Raises FY18 Guidance,2018-08-01 16:24:00-04:00,PKI,neutral
1013059.0,"PerkinElmer Q2 Adj. EPS $0.91 Beats $0.86 Estimate, Sales $703.4M Beat $693.01M Estimate",2018-08-01 16:23:00-04:00,PKI,neutral
1013060.0,PerkinElmer's Genomics Unit Forms Collaboration With Enzyvant For Access To Collection Packs For Patient Sample Intake,2018-07-19 08:28:00-04:00,PKI,neutral
1013061.0,PerkinElmer Acquires Shanghai Spectrum Instruments Co; Terms Not Disclosed,2018-05-24 04:38:00-04:00,PKI,neutral
1013062.0,"UBS Global Healthcare Conference 2018 Begins Today, Presenters Include: Deciphera Pharmaceuticals, Zymeworks, and PerkinElmer",2018-05-21 07:08:00-04:00,PKI,neutral
1013063.0,UPDATE: PerkinElmer Raises FY18 Adj. EPS Outlook From $3.50 to $3.60 vs $3.53 Est.,2018-04-30 17:01:00-04:00,PKI,neutral
1013064.0,PerkinElmer Raises FY18 Outlook,2018-04-30 16:18:00-04:00,PKI,neutral
1013065.0,"PerkinElmer Q1 Adj. EPS $0.63 Beats $0.61 Est., Sales $644M Beats $620M Est.",2018-04-30 16:18:00-04:00,PKI,neutral
1013066.0,"Earnings Scheduled For April 30, 2018",2018-04-30 05:48:00-04:00,PKI,neutral
1013067.0,PerkinElmer Names James Mock CFO,2018-04-10 16:30:00-04:00,PKI,negative
1013068.0,PerkinElmer Collaborates with Helix to Develop and Sell Personal Genomics Tests,2018-04-10 08:28:00-04:00,PKI,neutral
1013069.0,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,2018-02-26 07:09:00-05:00,PKI,neutral
1013070.0,"7 Stocks To Watch For February 26, 2018",2018-02-26 05:08:00-05:00,PKI,neutral
1013071.0,PerkinElmer to Acquire RHS for $0.28/Share,2018-02-25 17:47:00-05:00,PKI,neutral
1013072.0,PerkinElmer Sees FY18 Adj. EPS $3.50 vs $3.47 Est.,2018-01-25 16:15:00-05:00,PKI,neutral
1013073.0,"PerkinElmer Reports Q4 Adj. EPS $0.97 vs $0.94 Est., Sales $642M vs $618.6M Est.",2018-01-25 16:15:00-05:00,PKI,neutral
1013074.0,The 10 Most Expensive Stocks In The S&P 500,2018-01-23 13:23:00-05:00,PKI,neutral
1013075.0,PerkinElmer Hits 52-Week High: What's Driving The Stock?,2018-01-19 12:44:00-05:00,PKI,neutral
1013076.0,"JP Morgan Healthcare Conference Continues Today, Presenters Include: Quidel, NovoCure, Acorda, PerkinElmer, Glaukos, IDEXX, MiMedx, Community Health, Global Blood Therapeutics, and Ultragenyx",2018-01-10 09:03:00-05:00,PKI,positive
1013077.0,"Evercore ISI Group Initiates Coverage On PerkinElmer with In-Line Rating, Announces $77.00 Price Target",2018-01-04 08:44:00-05:00,PKI,neutral
1013078.0,Bank of America Upgrades PerkinElmer to Neutral,2017-12-19 08:45:00-05:00,PKI,neutral
1013079.0,PerkinElmer Sees FY17 Adj. EPS $2.87-$2.89 vs $2.88 Est.,2017-11-02 17:29:00-04:00,PKI,neutral
1013080.0,"PerkinElmer Reports Q3 Adj. EPS $0.73 vs $0.72 Est., Sales $554.5M vs $552.4M Est.",2017-11-02 17:28:00-04:00,PKI,neutral
1013081.0,"Baird Global Healthcare Conference Begins Today, Presenters Include: Tenet Healthcare, Mednax, Patterson Companies, Celgene, PerkinElmer, Premier, Acadia Healthcare, Envision Healthcare, and Enanta Pharmaceuticals",2017-09-06 09:11:00-04:00,PKI,neutral
1013082.0,PerkinElmer Sees FY17 Adj. EPS $2.84-$2.92 vs $2.86 Est.,2017-08-03 16:55:00-04:00,PKI,neutral
1013083.0,"PerkinElmer Reports Q2 Adj. EPS $0.67 vs $0.67 Est., Sales $547M vs $553M Est.",2017-08-03 16:55:00-04:00,PKI,neutral
1013084.0,Wells Fargo Initiates Coverage On PerkinElmer with Market Perform Rating,2017-07-13 06:56:00-04:00,PKI,positive
1013086.0,"PerkinElmer to Acquire EUROIMMUN for ~$1.3B; Reaffirms 2017 Revenue, EPS Guidance",2017-06-19 04:18:00-04:00,PKI,neutral
1013088.0,"Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag Diagnostics Products in Several African Countries, Israel",2017-05-30 04:14:00-04:00,PKI,positive
1013089.0,PerkinElmer Sees FY17 EPS $2.80-$2.90 vs $2.82 Est.,2017-05-04 17:00:00-04:00,PKI,neutral
1013090.0,"PerkinElmer Reports Q1 Adj. EPS $0.55 vs $0.54 Est., Sales $514M vs $506M Est.",2017-05-04 16:59:00-04:00,PKI,neutral
1013091.0,Cantor Fitzgerald Downgrades PerkinElmer to Neutral,2017-04-19 08:08:00-04:00,PKI,neutral
1013092.0,Janney Capital Upgrades PerkinElmer To Buy,2017-03-27 07:16:00-04:00,PKI,neutral
1013093.0,Bank of America Downgrades PerkinElmer To Underperform,2017-02-03 08:16:00-05:00,PKI,neutral
1013094.0,PerkinElmer Sees FY17 Adj. EPS $2.75-$2.85 vs $2.79 Est.,2017-02-02 16:25:00-05:00,PKI,neutral
1013095.0,"PerkinElmer Reports Q4 Adj. EPS $0.83 vs $0.86 Est., Sales $567M vs $609.7M Est.",2017-02-02 16:25:00-05:00,PKI,neutral
1013096.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,PKI,positive
1013097.0,"Deutsche Bank Initiates Coverage On PerkinElmer at Hold, Announces $55 Price Target",2017-01-18 08:55:00-05:00,PKI,neutral
1013098.0,"PerkinElmer Reports Purchase of Tulip diagnostics Private, No Terms Disclosed",2017-01-09 16:18:00-05:00,PKI,negative
1013099.0,PerkinElmer Narrows FY16 Adj. EPS Outlook from $2.75-$2.85 to $2.75-$2.77 vs $2.80 Est.,2016-11-07 16:25:00-05:00,PKI,neutral
1013100.0,"PerkinElmer Reports Q3 Adj. EPS $0.68 vs $0.66 Est., GAAP Sales $548M vs $563M in Same Qtr. Last Year",2016-11-07 16:24:00-05:00,PKI,neutral
1013101.0,Cleveland Research Sees Potential For Downside In PerkinElmer Shares In Q3 ANd FY17; Investors Likely To Focus on Future Portfolio Restructurings,2016-10-26 09:13:00-04:00,PKI,positive
1013102.0,"PerkinElmer Reports Realignment Into Two Business Units: Diagnostics, Discovery & Analytical Solutions",2016-09-26 08:01:00-04:00,PKI,positive
1013103.0,Just A Bump In The Road: 10 Stocks Which Have Resumed Rallying Today,2016-08-23 11:36:00-04:00,PKI,neutral
1013104.0,14 Stocks Which Staged A Strong End Of The Week,2016-08-19 13:38:00-04:00,PKI,positive
1013105.0,Mizuho Securities Downgrades PerkinElmer to Neutral,2016-08-05 06:17:00-04:00,PKI,positive
1013106.0,PerkinElmer Reaffirms FY16 Adj. EPS Outlook $2.75-$2.85 vs $2.80 Est.,2016-08-04 16:49:00-04:00,PKI,neutral
1013107.0,PerkinElmer Announces 8M Share Buyback Plan,2016-08-04 16:48:00-04:00,PKI,positive
1013108.0,"PerkinElmer Reports Q2 Adj. EPS $0.67 vs $0.66 Est., Sales $573M vs $574.8M Est.",2016-08-04 16:48:00-04:00,PKI,neutral
1013109.0,BTIG Research Assumes PerkinElmer at Neutral,2016-07-22 07:31:00-04:00,PKI,neutral
1013110.0,PerkinElmer Vol Spike,2016-05-25 10:52:00-04:00,PKI,neutral
1013111.0,"After-Hours Recap: Indexes Up Friday, But Still Down For The Week",2016-05-07 14:34:00-04:00,PKI,neutral
1013112.0,PerkinElmer Sees FY16 EPS $2.75-$2.85 vs. Est. $2.71,2016-05-05 16:29:00-04:00,PKI,neutral
1013113.0,"PerkinElmer Reports Q1 EPS $0.56 vs. Est. $0.51, Rev. $539M vs. Est. $532M",2016-05-05 16:28:00-04:00,PKI,neutral
1013114.0,PerkinElmer Sells Prenatal Screening Lab Services Unit To Eurofins Scientific,2016-04-25 08:29:00-04:00,PKI,neutral
1013115.0,"PerkinElmer Sells NTD Lab Services Business To Eurofins Scientific, Terms Not Disclosed",2016-04-25 07:27:00-04:00,PKI,neutral
1013116.0,Bank of America Downgrades PerkinElmer to Neutral,2016-04-05 07:06:00-04:00,PKI,neutral
1013117.0,"Barclays Initiates Coverage on PerkinElmer at Underweight, Announces $46.00 PT",2016-03-01 04:17:00-05:00,PKI,neutral
1013118.0,PerkinElmer Sees FY16 Adj. EPS $2.65-$2.75 vs $2.82 Est.,2016-02-04 16:20:00-05:00,PKI,neutral
1013119.0,"PerkinElmer Reports Q4 Adj. EPS $0.86 vs $0.87 Est., GAAP Sales $608.1M vs $617.5M Est.",2016-02-04 16:19:00-05:00,PKI,neutral
1013120.0,Cowen & Company Downgrades PerkinElmer to Market Perform,2016-01-07 08:54:00-05:00,PKI,neutral
1013121.0,Deutsche Bank Initiates Coverage on PerkinElmer at Hold,2016-01-06 16:22:00-05:00,PKI,neutral
1013122.0,Goldman Just Downgraded These Three Life Science Stocks,2015-12-08 08:15:00-05:00,PKI,neutral
1013123.0,"Goldman Sachs Downgrades PerkinElmer, Inc. Common Stock to Sell, Lowers PT to $44.00",2015-12-08 05:36:00-05:00,PKI,negative
1013124.0,Benzinga's Top Downgrades,2015-12-03 09:21:00-05:00,PKI,positive
1013125.0,"Wedbush Downgrades PerkinElmer Amid Growing FX, Ex-US Complexities",2015-12-03 08:34:00-05:00,PKI,positive
1013126.0,"Wedbush Downgrades PerkinElmer, Inc. Common Stock to Neutral, Maintains $56.00 PT",2015-12-03 06:47:00-05:00,PKI,neutral
1013127.0,14 Healthcare Stocks Fundstrat Is Buying,2015-10-05 11:39:00-04:00,PKI,neutral
1013128.0,"Cantor Fitzgerald Initiates Coverage on PerkinElmer at Buy, Announces $62.00 PT",2015-08-27 07:34:00-04:00,PKI,neutral
1013129.0,PerkinElmer Reports Q2 EPS $0.43 vs Est $0.59; Sees FY Cont. Ops EPS $2.00-$2.05 vs Est $2.59,2015-07-30 16:19:00-04:00,PKI,neutral
1013130.0,Benzinga's Top Downgrades,2015-05-04 09:11:00-04:00,PKI,positive
1013131.0,KeyBanc Downgrades PerkinElmer To Sector Weight,2015-05-04 08:47:00-04:00,PKI,neutral
1013132.0,"KeyBanc Downgrades PerkinElmer to Sector Weight, Removes $52.00 PT",2015-05-04 06:21:00-04:00,PKI,neutral
1013133.0,"PerkinElmer Reports Q1 Adj. EPS $$0.50 vs $0.46 Est., Sales $527.2M vs $540M Est.; Sees FY15 Adj. EPS $2.54-$2.60 vs $2.60 Est.",2015-04-30 16:18:00-04:00,PKI,neutral
1013134.0,"PerkinElmer Reports Q1 EPS $0.50 vs Est $0.46, Sales $200.8M Vs Est $537.88M",2015-04-30 16:06:00-04:00,PKI,neutral
1013135.0,UBS Initiates Coverage on PerkinElmer at Buy,2015-03-10 04:44:00-04:00,PKI,neutral
1013136.0,Quanterix Says Executive Chairman Hrusovsky To Work As CEO Also,2015-03-04 12:41:00-05:00,PKI,neutral
1013137.0,Fast Money Halftime Report Final Trade From January 28,2015-01-29 06:24:00-05:00,PKI,neutral
1013138.0,"JP Morgan Downgrades PerkinElmer to Neutral, Lowers PT to $45.00",2015-01-06 06:39:00-05:00,PKI,positive
1013139.0,FDA Allows Marketing Of First Newborn Screen Test,2014-12-15 16:57:00-05:00,PKI,neutral
1013140.0,PerkinElmer Completes Acquisition of Perten Instruments,2014-12-15 16:12:00-05:00,PKI,neutral
1013141.0,"Goldman Sachs Downgrades PerkinElmer, Inc. to Neutral",2014-12-02 06:00:00-05:00,PKI,neutral
1013142.0,PerkinElmer Reports Deal to Purchase Perten Instruments for ~$266M,2014-11-24 08:31:00-05:00,PKI,neutral
1013143.0,"Events for the Week of Nov. 17-21, 2014",2014-11-17 13:13:00-05:00,PKI,neutral
1013144.0,"PerkinElmer, Inc. Sees FY2014 EPS $2.39-2.41 vs $2.44 Est",2014-10-30 16:44:00-04:00,PKI,neutral
1013145.0,"PerkinElmer, Inc. Reports Q3 EPS of $0.57, Inline; Revenue of $542.90M vs $550.08M Est",2014-10-30 16:23:00-04:00,PKI,neutral
1013146.0,"Morgan Stanley Initiates Coverage on PerkinElmer, Inc. at Overweight, Announces $52.00 PT",2014-09-08 07:41:00-04:00,PKI,negative
1013147.0,Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest Dividend Yield,2014-09-02 05:00:00-04:00,PKI,positive
1013148.0,"Stifel Nicolaus Initiates Coverage on PerkinElmer, Inc. at Buy, Announces $53.00 PT",2014-08-12 06:36:00-04:00,PKI,neutral
1013149.0,"PerkinElmer, Inc. Reports Q2 EPS of $0.59, Inline; Revenue of $556.20M vs $571.68M Est",2014-07-31 16:14:00-04:00,PKI,neutral
1013150.0,Enzon Biochem To Receive $7M From PerkinElmer in Lawsuit Settlement,2014-06-23 07:32:00-04:00,PKI,negative
1013151.0,Moody's Affirms Ratings on PerkinElmer; Outlook Raised from Negative to Stable,2014-05-27 17:15:00-04:00,PKI,negative
1013152.0,"Janney Capital Upgrades PerkinElmer, Inc. to Buy, Raises PT to $50.00",2014-05-05 08:46:00-04:00,PKI,neutral
1013153.0,"PerkinElmer, Inc. Raises FY2014 EPS Guidance from $2.40-2.45 to $2.42-2.46 vs $2.45 Est",2014-04-24 16:19:00-04:00,PKI,neutral
1013154.0,"PerkinElmer, Inc. Reports Q1 EPS of $0.46 vs $0.44 Est; Revenue of $232.40M vs $531.31M Est",2014-04-24 16:09:00-04:00,PKI,neutral
1013155.0,"ISI Group Downgrades PerkinElmer, Inc. to Neutral",2014-04-09 08:17:00-04:00,PKI,neutral
1013156.0,"PerkinElmer, Good Start Genetics Report Collaboration to Bring GoodStart Selectâ„¢ Carrier Screening Tests to Broader Women's Health Market",2014-03-17 07:49:00-04:00,PKI,positive
1013157.0,"PerkinElmer, Inc. Sees FY2014 EPS $2.40-2.45 vs $2.42 Est",2014-01-30 16:25:00-05:00,PKI,neutral
1013158.0,"PerkinElmer, Inc. Reports Q4 EPS of $0.73 vs $0.70 Est; Revenue of $593.30M vs $589.10M Est",2014-01-30 16:25:00-05:00,PKI,neutral
1013159.0,"Bank of America Maintains Buy on PerkinElmer, Inc., Raises PO to $44.00",2013-12-12 06:36:00-05:00,PKI,negative
1013160.0,"Macquarie Upgrades PerkinElmer, Inc. to Outperform, Raises PT to $45.00",2013-12-10 08:14:00-05:00,PKI,neutral
1013161.0,"Jefferies Maintains Hold on PerkinElmer, Inc., Raises PT to $36.00",2013-10-31 08:33:00-04:00,PKI,neutral
1013162.0,"PerkinElmer, Inc. Narrows FY2013 EPS Guidance from $2.03-2.10 to $2.04-2.07 vs $2.07 Est",2013-10-30 16:27:00-04:00,PKI,neutral
1013163.0,"PerkinElmer, Inc. Reports Q3 EPS of $0.49 vs $0.48 Est; Revenue of $525.10M vs $523.58M Est",2013-10-30 16:27:00-04:00,PKI,neutral
1013164.0,UPDATE: Piper Jaffray Initiates Coverage on PerkinElmer on Multiple Positive Factors,2013-09-17 10:56:00-04:00,PKI,positive
1013165.0,Benzinga's Top Initiations,2013-09-17 07:52:00-04:00,PKI,positive
1013166.0,"Piper Jaffray Initiates Coverage on PerkinElmer, Inc. at Overweight, Announces $46.00 PT",2013-09-17 07:11:00-04:00,PKI,negative
1013167.0,"Piper Jaffray Initiates Coverage on PerkinElmer, Inc. at Overweight, Announces $46.00 PT",2013-09-16 17:44:00-04:00,PKI,negative
1013168.0,"Janney Capital Initiates Coverage on PerkinElmer, Inc. at Neutral, Announces $40.00 PT",2013-08-15 08:45:00-04:00,PKI,neutral
1013169.0,"PerkinElmer, Inc. Raises FY2013 EPS Guidance from $2.00-2.10 to $2.03-2.10 vs $1.93 Est",2013-08-01 16:11:00-04:00,PKI,neutral
1013170.0,"PerkinElmer, Inc. Reports Q2 EPS of $0.51 vs $0.48 Est; Revenue of $543.30M vs $532.96M Est",2013-08-01 16:10:00-04:00,PKI,neutral
1013171.0,Dow Jones Reporting Perkin Elmer Unit to Sell Boston Facility for $49.5M,2013-07-22 16:13:00-04:00,PKI,neutral
1013172.0,"Market Wrap for Friday, April 26: Major Averages Mixed to Close Out Week",2013-04-26 16:29:00-04:00,PKI,neutral
1013173.0,UPDATE: ISI Group Downgrades PerkinElmer to Buy on Disappointing Quarter Results,2013-04-26 10:22:00-04:00,PKI,negative
1013174.0,Benzinga's Top Downgrades,2013-04-26 07:59:00-04:00,PKI,positive
1013175.0,"ISI Group Downgrades PerkinElmer, Inc. to Buy, Lowers PT to $36.00",2013-04-26 06:45:00-04:00,PKI,negative
1013176.0,"PerkinElmer, Inc. Reports Q1 EPS of $0.36 vs $0.48 Est; Revenue of $505.40M vs $532.75M Est",2013-04-25 16:22:00-04:00,PKI,neutral
1013177.0,"Citigroup Initiates Coverage on PerkinElmer, Inc. at Neutral, Announces $36.00 PT",2013-04-18 06:31:00-04:00,PKI,neutral
1013178.0,PerkinElmer Files Automatic Mixed Securities Shelf,2013-03-21 16:29:00-04:00,PKI,positive
1013179.0,"Jefferies Maintains Hold on PerkinElmer, Inc., Raises PT to $40.00",2013-02-01 08:43:00-05:00,PKI,neutral
1013180.0,"PerkinElmer, Inc. Sees FY2013 EPS $2.24-2.32 vs $2.27 Est",2013-01-31 16:14:00-05:00,PKI,neutral
1013181.0,"PerkinElmer, Inc. Reports Q4 EPS of $0.65, Inline; Revenue of $572.90M",2013-01-31 16:13:00-05:00,PKI,neutral
1013182.0,"CLSA Upgrades PerkinElmer, Inc. to Buy, Raises PT to $48.00",2013-01-17 07:55:00-05:00,PKI,neutral
1013183.0,"PerkinElmer, Verinata Health Announce Collaboration to Expand Access to Non-Invasive Prenatal Test for Chromosomal Abnormalities",2013-01-09 08:06:00-05:00,PKI,positive
1013184.0,UPDATE: Morgan Stanley Upgrades PerkinElmer to Overweight on Operating Margin Outlook  ,2013-01-04 08:29:00-05:00,PKI,negative
1013185.0,"Morgan Stanley Upgrades PerkinElmer, Inc. to Overweight, Announces $38.00 PT",2013-01-04 07:13:00-05:00,PKI,negative
1013186.0,"Morgan Stanley Upgrades PerkinElmer, Inc. to Overweight",2013-01-03 16:22:00-05:00,PKI,negative
1013187.0,PerkinElmer Acquires China-based Infectious Disease Diagnostics Company  ,2012-11-12 16:21:00-05:00,PKI,neutral
1013188.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on PerkinElmer",2012-10-26 12:59:00-04:00,PKI,neutral
1013189.0,"UBS Maintains PerkinElmer at Buy, Raises PT from $32 to $33",2012-10-26 10:44:00-04:00,PKI,neutral
1013190.0,"Jefferies & Company Maintains PerkinElmer at Hold, Raises PT from $30 to $32",2012-10-26 07:55:00-04:00,PKI,neutral
1013191.0,UPDATE: JP Morgan Initiates PerkinElmer at Overweight on Long-Term Outlook,2012-10-03 09:18:00-04:00,PKI,neutral
1013192.0,"JP Morgan Initiates Coverage on PerkinElmer at Overweight, Announces PT of $37",2012-10-03 05:54:00-04:00,PKI,neutral
1013193.0,Cowen Initiates Coverage PerkinElmer at Neutral,2012-10-02 08:16:00-04:00,PKI,neutral
1013194.0,UPDATE: PerkinElmer Q2 Profit Up 13%,2012-08-03 00:05:00-04:00,PKI,positive
1013195.0,PerkinElmer Reports Q2 EPS $0.53 vs $0.49 Est; Revenues $521.8M vs $537.05M Est,2012-08-02 16:06:00-04:00,PKI,neutral
1013196.0,"Barlcays Maintains PerkinElmer at Equal-weight, Raises PT from $24 to $26",2012-07-23 12:35:00-04:00,PKI,neutral
1013197.0,"UPDATE: ISI Group Initiates PerkinElmer with Overweight, $29 PT on Demand for Inorganic Analysis  ",2012-07-10 10:17:00-04:00,PKI,negative
1013198.0,"ISI Group Initiates Coverage on PerkinElmer at Overweight, Announces PT of $29.50",2012-07-10 06:07:00-04:00,PKI,negative
1013199.0,Goldman Sachs Adds PerkinElmer to CL-Buy List,2012-06-19 06:53:00-04:00,PKI,neutral
1013200.0,"UBS Maintains PerkinElmer at Buy, Raises PT from $30 to $32",2012-04-27 10:45:00-04:00,PKI,neutral
1013201.0,PerkinElmer Reports Q1 EPS $0.43 vs $0.41 Est; Revenues $510.9M vs $510.35M Est,2012-04-26 16:22:00-04:00,PKI,neutral
1013202.0,"Morgan Stanley Initiates Coverage on PerkinElmer at Equal-weight,  from $  to $ ",2012-03-06 09:38:00-05:00,PKI,neutral
1013203.0,Perkelmer Guides FY2012 EPS $1.98-2.04 vs $1.91 Est,2012-02-02 16:33:00-05:00,PKI,neutral
1013204.0,PerkinElmer Reports Q4 EPS $0.62 vs $0.51 Est; Revenues $540.2M vs $537.06M Est	 			,2012-02-02 16:16:00-05:00,PKI,neutral
1013205.0,Top Performing Health Care Stocks in January,2012-02-01 06:32:00-05:00,PKI,positive
1013206.0,PerkinElmer Hits 52-Week Low of $17.48,2011-11-25 12:09:00-05:00,PKI,negative
1013207.0,UPDATE: Deutsche Bank Lowers PT on PerkinElmer to $20,2011-11-04 08:22:00-04:00,PKI,negative
1013208.0,PerkinElmer Reports Q3 EPS $0.24 vs $0.39 Est; Revenues $453.70M vs $469.61M Est			,2011-11-03 16:31:00-04:00,PKI,neutral
1013209.0,PerkinElmer Spiking Higher on Takeover Chatter,2011-10-25 14:08:00-04:00,PKI,neutral
1013210.0,PerkinElmer Prices Offering of Senior Notes   ,2011-10-21 08:05:00-04:00,PKI,neutral
1013211.0,UPDATE: Deutsche Bank Downgrades Perkin Elmer to Hold,2011-10-05 07:49:00-04:00,PKI,neutral
1013212.0,"Financial Breakfast: Morning News Summary for October 5, 2011",2011-10-05 07:41:00-04:00,PKI,neutral
1013213.0,"Deutsche Bank Downgrades PerkinElmer to Hold, PT Lowered to $21",2011-10-05 06:07:00-04:00,PKI,negative
1013214.0,Deutsche Bank Comments on PerkinElmer's Acquisition of Caliper Life Sciences,2011-09-14 09:07:00-04:00,PKI,neutral
1013215.0,WidePoint's Subsidiary ORC Announces New Hosted Authorization and e-Passport Validation Service in Partnership ,2011-09-13 09:30:00-04:00,PKI,neutral
1013216.0,"Thursday's NASDAQ Top Gainers: Caliper Life Sciences, Penn Millers, Tangoe, BSD Medical",2011-09-09 11:03:00-04:00,PKI,positive
1013217.0,"Financials, Industrials, and Basic Materials Slide into the Close",2011-09-08 15:35:00-04:00,PKI,neutral
1013218.0,Thursday's Top Percentage Gainers and Losers,2011-09-08 14:37:00-04:00,PKI,negative
1013219.0,PerkinElmer To Acquire Caliber in $600 Million Deal,2011-09-08 13:16:00-04:00,PKI,neutral
1013220.0,Top Narrow Based Indexes For September 8,2011-09-08 10:01:00-04:00,PKI,positive
1013221.0,Morning Market Movers,2011-09-08 09:45:00-04:00,PKI,neutral
1013222.0,Benzinga's Top Pre-Market Gainers,2011-09-08 07:42:00-04:00,PKI,positive
1013223.0,A Peek Into The Market Before The Trading Starts,2011-09-08 07:26:00-04:00,PKI,neutral
1013224.0,PerkinElmer to Acquire Caliper Life Sciences for $10.50 per Share Totaling $600 Million   ,2011-09-08 07:00:00-04:00,PKI,positive
1013225.0,U of Colorado Opens Cord Blood Bank: What About Cord Blood Stocks,2011-09-07 13:01:00-04:00,PKI,neutral
1013226.0,Roche and PerkinElmer Enter into New Agreement for Distribution of NimbleGen CGX Cytogenetics ,2011-08-18 08:05:00-04:00,PKI,positive
1013227.0,Deutsche Bank Updates 7/11/11,2011-07-11 07:49:00-04:00,PKI,neutral
1013228.0,Deutsche Bank Healthcare Services PT Changes 7/11,2011-07-11 06:06:00-04:00,PKI,neutral
1013229.0,Gene Sequencing's Advance Leads To Cloud,2011-06-16 17:44:00-04:00,PKI,neutral
1013230.0,PerkinElmer Acquires Dexela Limited,2011-06-13 08:07:00-04:00,PKI,negative
1013231.0,PerkinElmer Reports EPS of $0.34 vs. $0.31 Estimate; Revenues $447.9M vs. $424.65M Estimate (PKI),2011-05-05 16:23:00-04:00,PKI,neutral
1013232.0,Jefferies Maintains Hold on PerkinElmer (PKI),2011-03-25 08:35:00-04:00,PKI,neutral
1013233.0,PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation ,2011-03-24 08:00:00-04:00,PKI,positive
1013234.0,"Cramer's St. Patrick's Day Picks (PKI, WFC)",2011-03-17 14:48:00-04:00,PKI,neutral
1013235.0,Cramer Positive on PerkinElmer (PKI),2011-03-17 14:36:00-04:00,PKI,positive
1013236.0,"Zings Of The Day (PKI, NWSA)",2011-02-25 15:59:00-05:00,PKI,neutral
1013237.0,President Obama's FY2012 Budget Details Released,2011-02-14 09:21:00-05:00,PKI,neutral
1013238.0,PerkinElmer Acquires chemagen Biopolymer-Technologie AG,2011-02-14 08:15:00-05:00,PKI,neutral
1013239.0,UBS Price Target Research Summary,2011-02-04 10:31:00-05:00,PKI,neutral
1013240.0,PerkinElmer Completes Divestiture of IDS Business ,2010-11-29 16:47:00-05:00,PKI,neutral
1013241.0,PerkinElmer Completes Divestiture of IDS Business ,2010-11-29 16:47:00-05:00,PKI,neutral
1013242.0,PerkinElmer Remains Neutral - Analyst Blog,2010-11-16 16:33:00-05:00,PKI,neutral
1013243.0,PerkinElmer Beats Estimates - Analyst Blog,2010-11-05 12:32:00-04:00,PKI,neutral
1013244.0,PerkinElmer Board Declares Quarterly Dividend of $0.07,2010-10-27 16:49:00-04:00,PKI,neutral
1013245.0,Barclays Capital Upgrades PKI To Equal Weight,2010-10-11 06:56:00-04:00,PKI,neutral
1013246.0,"Jefferies Initiates Coverage On SIRO, XRAY, CALP, DENX, DHR, PKI",2010-10-06 09:23:00-04:00,PKI,neutral
1013247.0,Life Sciences Research From Jefferies,2010-09-27 08:52:00-04:00,PKI,neutral
1013248.0,"Company News for September 1, 2010 - Corporate Summary",2010-09-01 13:03:00-04:00,PKI,neutral
1013249.0,"Stocks To Watch For September 1 (HNZ, PKI, PSS, HPQ, SAI)",2010-09-01 05:04:00-04:00,PKI,neutral
1013250.0,Top Cord Blood Stocks,2010-08-26 10:53:00-04:00,PKI,positive
1013251.0,PerkinElmer Stays at Neutral - Analyst Blog,2010-08-10 11:03:00-04:00,PKI,neutral
1013252.0,Perkin Elmer Beats the Street - Analyst Blog,2010-08-06 16:35:00-04:00,PKI,neutral
1013253.0,PerkinElmer Shares Up 11% (PKI),2010-08-06 12:31:00-04:00,PKI,positive
1013254.0,VeriSign Sells Business Unit - Analyst Blog,2010-05-21 15:27:00-04:00,PKI,neutral
1013255.0,"Company News for May 7, 2010 - Corporate Summary",2010-05-07 09:45:00-04:00,PKI,neutral
1013256.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,PKI,positive
1013257.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,PKI,neutral
1013258.0,Monday's Hot Stocks: Brush Up your Portfolio with Sirona Dental,2010-02-23 08:52:00-05:00,PKI,neutral
1013259.0,VASCO Launches New Version of DIGIPASS CertiID,2009-09-03 06:01:00-04:00,PKI,neutral
1013260.0,"WallStSense.com Fundamental & Technical Coverage of PAY, SNA, VLY, AU, HSP and PKI",2009-08-18 06:27:00-04:00,PKI,negative
1013261.0,RIM Announces Next Generation BlackBerry Smart Card Reader,2009-08-17 07:00:00-04:00,PKI,positive
1013262.0,Todos AB joins OATH,2009-08-13 05:06:00-04:00,PKI,neutral
